Cutting Copays Act
This bill eliminates cost-sharing for generic drugs for those with the lowest-income under the Medicare prescription drug benefit's Low-Income Subsidy Program beginning in 2026.
[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[S. 3951 Introduced in Senate (IS)]
<DOC>
118th CONGRESS
2d Session
S. 3951
To amend title XVIII of the Social Security Act to provide for
adjustments to the Medicare part D cost-sharing reductions for low-
income individuals.
_______________________________________________________________________
IN THE SENATE OF THE UNITED STATES
March 14, 2024
Mr. Casey introduced the following bill; which was read twice and
referred to the Committee on Finance
_______________________________________________________________________
A BILL
To amend title XVIII of the Social Security Act to provide for
adjustments to the Medicare part D cost-sharing reductions for low-
income individuals.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ``Cutting Copays Act''.
SEC. 2. ADJUSTMENTS TO MEDICARE PART D COST-SHARING REDUCTIONS FOR LOW-
INCOME INDIVIDUALS.
Section 1860D-14(a) of the Social Security Act (42 U.S.C. 1395w-
114(a)) is amended--
(1) in paragraph (1)(D)(ii), by striking ``that does not
exceed $1 for'' and all that follows through the period at the
end and inserting ``that does not exceed--
``(I) for a plan year before 2026--
``(aa) for a generic drug
or a preferred drug that is a
multiple source drug (as
defined in section
1927(k)(7)(A)(i)), $1 or, if
less, the copayment amount
applicable to an individual
under clause (iii); and
``(bb) for any other drug,
$3 or, if less, the copayment
amount applicable to an
individual under clause (iii);
and
``(II) for plan year 2026 and each
subsequent plan year--
``(aa) for a generic drug,
$0;
``(bb) for a preferred drug
that is a multiple source drug
(as defined in section
1927(k)(7)(A)(i)), the dollar
amount applied under this
clause for such a drug for the
preceding year, increased by
the annual percentage increase
in the consumer price index
(all items; U.S. city average)
as of September of such
preceding year, or, if less,
the copayment amount applicable
to an individual under clause
(iii); and
``(cc) for a drug not
described in either item (aa)
or (bb), the dollar amount
applied under this clause for
such a drug for the preceding
year, increased in the manner
specified in item (bb), or, if
less, the copayment amount
applicable to an individual
under clause (iii).
Any amount established under item (bb) or (cc)
of subclause (II), that is based on an increase
of $1 or $3, that is not a multiple of 5 cents
or 10 cents, respectively, shall be rounded to
the nearest multiple of 5 cents or 10 cents,
respectively.''; and
(2) in paragraph (4)(A)(ii), by inserting ``(before 2026)''
after ``a subsequent year''.
<all>
Introduced in Senate
Read twice and referred to the Committee on Finance.
Llama 3.2 · runs locally in your browser
Ask anything about this bill. The AI reads the full text to answer.
Enter to send · Shift+Enter for new line